Dennis Mulroy
Chief Financial Officer, Gene Biotherapeutics, Inc.
Companies
- Arcturus TherapeuticsChief financial officer May 7, 2026 to now1
- ANAPTYSBIO, INCChief financial officer Jul 15, 2020 to May 13, 20262
- La Jolla Pharmaceutical CompanyChief financial officer Apr 8, 2015 to Jun 2, 20203
- Gene Biotherapeutics, Inc.Chief financial officer Mar 17, 2009 to Mar 4, 20144
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ANAPTYSBIO, INC ANAB21,852 shares5$1.0M at $47.42Jan 8, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 8, 2026Sold 2,515 shares at $44.71 of ANAPTYSBIO, INC5
- Jan 7, 2026Sold 1,908 shares at $45.11 of ANAPTYSBIO, INC6
- Jan 7, 2026Exercised options 6,700 shares of ANAPTYSBIO, INC5
- Jan 6, 2026Exercised options 5,245 shares of ANAPTYSBIO, INC6
- Jan 5, 2026Sold 3,363 shares at $43.26 of ANAPTYSBIO, INC7
- Jan 3, 2026Exercised options 8,292 shares of ANAPTYSBIO, INC7
- Dec 22, 2025Sold 10,000 shares at $50.00 of ANAPTYSBIO, INC8
- Dec 22, 2025Exercised options 10,000 shares at $20.16 of ANAPTYSBIO, INC8
- Dec 16, 2025Sold 6,360 shares at $45.21 of ANAPTYSBIO, INC9
- Dec 16, 2025Sold 9,365 shares at $44.62 of ANAPTYSBIO, INC9
- Dec 16, 2025Exercised options 10,000 shares at $20.16 of ANAPTYSBIO, INC9
- Jan 6, 2025Shares withheld for tax 2,054 shares at $15.30 of ANAPTYSBIO, INC10
- Jan 6, 2025Exercised options 5,245 shares of ANAPTYSBIO, INC10
- Jan 3, 2025Shares withheld for tax 3,407 shares at $14.60 of ANAPTYSBIO, INC10
- Jan 3, 2025Exercised options 8,293 shares of ANAPTYSBIO, INC10
- Sep 16, 2024Sold 10,000 shares at $40.13 of ANAPTYSBIO, INC11
- Sep 16, 2024Exercised options 10,000 shares at $20.16 of ANAPTYSBIO, INC11
- Sep 16, 2024Sold 2,220 shares at $38.93 of ANAPTYSBIO, INC11
- Sep 14, 2024Exercised options 6,000 shares of ANAPTYSBIO, INC11
- May 22, 2024Sold 1,500 shares at $23.72 of ANAPTYSBIO, INC12
- Jan 30, 2024Sold 3,065 shares at $23.63 of ANAPTYSBIO, INC13
- Jan 8, 2024Sold 2,180 shares at $21.81 of ANAPTYSBIO, INC14
- Jan 6, 2024Exercised options 5,245 shares of ANAPTYSBIO, INC14
- Sep 18, 2023Sold 3,895 shares at $19.32 of ANAPTYSBIO, INC15
- Sep 14, 2023Sold 2,105 shares at $19.48 of ANAPTYSBIO, INC15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jan 8, 2026
- 7SEC EDGARForm 4 filed Jan 6, 2026
- 8SEC EDGARForm 4 filed Dec 23, 2025
- 9SEC EDGARForm 4 filed Dec 18, 2025
- 10SEC EDGARForm 4 filed Jan 7, 2025
- 11SEC EDGARForm 4 filed Sep 17, 2024
- 12SEC EDGARForm 4 filed May 24, 2024
- 13SEC EDGARForm 4 filed Feb 1, 2024
- 14SEC EDGARForm 4 filed Jan 9, 2024
- 15SEC EDGARForm 4 filed Sep 18, 2023